OMX Copenhagen 20
2.095,60
PKT
+75,49
PKT
+3,74
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
07.03.16 | Novo Nordisk Sell | UBS AG | |
07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
09.02.16 | Novo Nordisk Halten | Independent Research GmbH | |
08.02.16 | Novo Nordisk Sell | UBS AG | |
04.02.16 | Novo Nordisk overweight | Barclays Capital | |
04.02.16 | Novo Nordisk Neutral | UBS AG | |
04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.16 | Novo Nordisk verkaufen | S&P Capital IQ | |
01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
01.02.16 | Novo Nordisk Neutral | UBS AG | |
01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
14.01.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
08.01.16 | Novo Nordisk overweight | Barclays Capital | |
07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
10.12.15 | Novo Nordisk Neutral | BNP PARIBAS | |
02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
01.12.15 | Novo Nordisk Halten | Independent Research GmbH | |
30.11.15 | Novo Nordisk Hold | Deutsche Bank AG | |
25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
20.11.15 | Novo Nordisk Neutral | UBS AG | |
20.11.15 | Novo Nordisk buy | Citigroup Corp. | |
20.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
20.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
19.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. |